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Abstract: Background: The idea of reusing dispensed medicines is appealing to the general public
provided its benefits are illustrated, its risks minimized, and the logistics resolved. For example,
medicine reuse could help reduce medicinal waste, protect the environment and improve public
health. However, the associated technologies and legislation facilitating medicine reuse are generally
not available. The availability of suitable technologies could arguably help shape stakeholders’
beliefs and in turn, uptake of a future medicine reuse scheme by tackling the risks and facilitating
the practicalities. A literature survey is undertaken to lay down the groundwork for implementing
technologies on and around pharmaceutical packaging in order to meet stakeholders’ previously
expressed misgivings about medicine reuse (’stakeholder requirements’), and propose a novel
ecosystem for, in effect, reusing returned medicines. Methods: A structured literature search
examining the application of existing technologies on pharmaceutical packaging to enable medicine
reuse was conducted and presented as a narrative review. Results: Reviewed technologies are
classified according to different stakeholders’ requirements, and a novel ecosystem from a technology
perspective is suggested as a solution to reusing medicines. Conclusion: Active sensing technologies
applying to pharmaceutical packaging using printed electronics enlist medicines to be part of the
Internet of Things network. Validating the quality and safety of returned medicines through this
network seems to be the most effective way for reusing medicines and the correct application of
technologies may be the key enabler.
Keywords: reuse of medicines; reduce medicinal waste; intelligent pharmaceutical packaging;
medicine re-dispensing; theory of planned behavior
1. Introduction
Medicinal waste has not only been a problem in the NHS (National Health Service) [1],
but also a challenge in other countries in terms of public health, the environment and governmental
expenditures [2–4]. Trueman et al. [5] reported that £300M of prescribed medicines are wasted every
year mainly through medication non-adherence. Together with those unused, unwanted and unexpired
medicines, they are major sources of preventable medicinal waste that can currently only be disposed
of through managed (e.g., disposal centers at community pharmacies) and unmanaged methods (e.g.,
domestic sewage, public bins, etc.). One of the ways to tackle medicinal waste is to explore the idea
of medicine reuse, which is currently not permitted in the UK [6,7]. A legally approved re-dispensing
of medicines scheme has started to work in some areas of the world such as the SIRUM (Supporting
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Initiatives to Redistribute Unused Medicine (https://www.sirum.org/)) originating from the California [8],
the Pharmaceutical donation and reuse programs operating now in many states of the US [9], and the GivMed
(https://givmed.org/en/) programme facilitating access to leftover medicines using a smartphone app in
Greece [7]. However, there are restrictions to the types and the sources of medicines to be reused since the
quality and safety of the returned medicines are not guaranteed [10]. Donating medicines to remote areas
that lack resources is another way of reducing medicinal waste through recycling medicines. Nevertheless,
the reusing of dispensed medicines is generally not allowed because a proper way of validating the
quality of returned medicines is not yet available. Thus, prescribed medicines from individuals are
usually not allowed to be donated abroad either [11,12]. A sustainable pharmaceutical supply chain
(PSC) management may provide an alternative solution to reducing medicinal waste through the concept
of reverse flows. Viegas et al. [13] classifies reverse flows into donation, Reverse Logistics (RL) and
Circular Economy (CE), where CE illustrates a close loop supply chain paving the way to reuse returned
medicines. The complicated communication flows between a large number of PSC stakeholders could be
an obstacle blocking a smooth reverse flow implementation. Pharma 4.0, an extension of Industry 4.0 to
pharmaceutical manufacturing, may help establish seamless connections between stakeholders through
Internet of Things (IoT) technologies [14,15]; however, the big concern in managing and monitoring the
quality of returned medicines still needs to be resolved.
The reuse of medicines is a behavior that can be studied using behavioral sciences [16,17].
Within this perspective, technologies are essential to facilitate attitude change by validating that
the medicines returned back to pharmacies have maintained their quality and are safe to use [18,19].
The reuse of prescribed medicines, especially in the UK, is an underexplored research area and the
corresponding technologies facilitating this action seem to be an uncharted territory. A structured
literature review is reported in this paper to categorize the required technologies applicable to the
design of pharmaceutical packaging facilitating the reuse of medicines and the reduction of medicinal
waste. Pharmaceutical packaging provides much useful information about a medicine and its use.
Additional data regarding its quality and safety which are critical for re-dispensing returned medicines
can also be monitored when appropriate technology is applied [20].
Pharmaceutical packaging is regarded as the “key facilitator” for establishing a friendly
patient-medication relationship through a patient-centered strategy [21], thus, embedding suitable
technologies onto the packaging itself seems to be the best approach for developing the concept of
medicine reuse. Manufacturers have already begun implementing technologies into pharmaceutical
packaging in order to provide clear information to patients, to protect medicines from the environment,
and to cope with changing government regulations and policies [22–25]. The main targets for applying
embedded technologies to the packaging are normally focusing on supply chain management [21,26],
anti-counterfeit enforcement [27,28], and quality and safety indications [29,30]. Static technologies
dominate previous research on pharmaceutical packaging where the interaction with the package
requires an external system such as a RFID (radio frequency identification) reader or barcode scanner
using a one-way data transmission protocol. Some of these static technologies may require human
interaction to identify their readings such as the TTI (time–temperature indicators) sensing devices
extensively used in the food packaging industry [31]. Alternatively, active technologies provide a better
package-to-human interaction based on the packaging itself. However, a higher degree of integration
of latest digital technologies with the pharmaceutical packaging is required for communicating with
the surrounding or remote computing devices. Connection to the Internet using the IoT concept is a
new technological trend for telehealthcare empowering a ubiquitous communication with technology
embedded pharmaceutical packaging based on cyber-physical systems (CPS) [15,32]. Intelligent
packaging, a term extensively used in food packaging, has been implementing both passive and active
technologies to inform consumers of the condition of the packaged food [33]. Many technologies
used in intelligent food packaging, especially those related to sensing and reporting, can also be
applied to pharmaceutical packaging. Emerging multidisciplinary research has enabled technologies
to be more effectively applied to reduce medicinal waste through enhancing medication adherence,
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particularly those studies based on the analysis of human behaviors through a combination of
psychology, medication and pharmacy [34,35]. Similarly, it could be argued that the application
of technology could influence people to engage in medication reuse by addressing the relevant
determinants of intentions to take part in such a scheme in the future. Qualitative studies, as well
as the application of the theory of planned behavior (TPB) have previously analyzed intentions and
actions towards the returning and re-dispensing of medicines [16–19], and there are technologies that
can help shape user behaviors towards the goal of medicines reuse.
As a precursor to defining a medicine reuse ecosystem, this research conducts a structured
literature survey and summarizes the technologies that can be applied to facilitating behavioral
changes towards reusing returned medicines. The terms reuse, re-dispense and recycle of medicines
are used interchangeably in the current article, distinguishing them from unwanted medicines that
need to be disposed of or incinerated, and which will be treated via medicine disposal through waste
management. Section 2 describes the structured literature review method used in the searching and
screening of peer review papers from popular academic search engines, and how the definitions
of inclusion and exclusion are made. The results are presented in Section 3 where a taxonomy of
technologies are classified according to the different factors affecting human behaviors. Discussions are
made in Section 4 with regard to how the technologies identified in this study can be used to facilitate
reuse with their pros and cons further elaborated. A medicine reuse management ecosystem based on
the result of the literature review is proposed from a technology perspective and Section 5 explains its
structure. Finally, Section 6 concludes the present study and lays down future research directions.
2. Methods
A structured literature review was conducted to identify and categorize the available technologies
that can help design pharmaceutical packaging to facilitate the reuse of returned prescribed medicines.
A rapid scoping review approach based on the PRISMA (Preferred Reporting Items for Systematic
reviews and Meta-Analyses) protocol was chosen for the literature survey using a single reviewer,
but with awareness of the limitations of not conducting a full multiple-reviewer systematic review [36,37].
The current study focuses on examining a novel concept of implementing appropriate technologies to
facilitate the shaping of human behaviors for medicine reuse. PRISMA protocol provided a structured,
reproducible and transparent methodology to conduct the article search, and using a single reviewer
enabled a rapid review approach which fit the purpose for laying down the groundwork for a future full
systematic review of specific studies identified in the present research [38].
Understanding human behaviors is essential in providing healthcare to the general public.
Continuous education and constant enhancement of services are essential to influence individual
decisions towards planned directions [39]. Previous studies have shown that patients and stakeholders
in the pharmaceutical sector generally accept the concept of reusing dispensed medicines as long
as certain criteria are met. Bekker et al. [17] investigated patients’ willingness to use recycled
medicines, McRae et al. [18] looked at the same issue through the healthcare professionals’ perspective,
and Bekker et al. [16] went further to collect the views from all related stakeholders. A more systematic
analysis of human behaviors for reuse of medicines in the UK was reported by Alhamad et al. [19],
and the three beliefs based on the TPB were studied using a thematic analysis of the associated attitudes
after interviewing the local community. The criteria from these empirical studies are similar and the
technological requirements are summarized in Table 1.
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Table 1. Technological Requirements for the Reuse of Medicines.
Requirements Quality Safety Others
Patients’
perspective [17]
(1) storage and handling
conditions.
(1) tamper-proof
packaging;
(2) anti-counterfeit.
(1) patient incentive;
(2) cost effectiveness.
Healthcare
professionals’
perspective [18]
(1) storage conditions
(temperature, moisture
and light);
(2) contamination of
package (stain, smell);
(3) last dispensing date.
(1) tamper-proof
packaging;
(2) anti-counterfeit.
(1) cost effectiveness;
(2) legal issues regarding
pharmacist responsibility,
medicine recall,
paperwork, efficacy,
and governmental
regulations.
Stakeholders’
perspective [16]
(1) monitor storage
conditions (temperature,
light, humidity, agitation,
and lapsed expiration
date).
(1) anti-counterfeit
(2) track and trace system
to the packages for
re-dispensed medicines
(1) patients’ incentive;
(2) pharmacists’
incentive;
(3) cost benefits shared
by stakeholders (patients,
pharmacists and health
insurance companies).
TPB Behavioral
beliefs [19]
(1) storage conditions
(temperature, humidity
and cleanliness);
(2) contaminated
packaging.
(1) tamper-proof
packaging;
(2) errors introduced by
patients or pharmacists;
(3) anti-counterfeit.
(1) cost effectiveness.
TPB Normative
beliefs [19]
Nil Nil (1) concern mostly on the
social norm for reusing
medicines.
TPB Control
beliefs [19]
(1) monitor storage
conditions (temperature,
light, humidity, agitation,
and lapsed expiration
date).
(1) tamper-proof
packaging;
(2) anti-counterfeit.
(1) patient incentive;
(2) on-site and
off-site collection and
distribution system.
Pharmaceutical packaging is not the only place for implementing technologies to facilitate
the shaping of human behaviors towards reusing returned medicines, associated technologies
working cohesively with the sensor embedded packaging are also essential in supporting related
activities. Therefore, the literature review for the present study has focused on both the technologies
implementable on the packaging and those that extend the embedded pharmaceutical packaging to
the outside world such as the Internet in order to share the information with every stakeholder. Table 1
provides the requirements for shaping the stakeholders’ behaviors for medicine reuse based on the
qualitative research described previously, and Table 2 illustrates a consolidated version removing
duplicates and converting the requirements into keywords for conducting the literature search.
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Table 2. Keywords for literature search according to the requirements listed in Table 1.
Requirements Technologies Keywords for Search
Quality (1) storage temperature monitoring
(2) storage humidity monitoring
(3) storage lighting monitoring
(4) storage contamination monitoring
(5) agitation monitoring
(6) lapsed expiration date monitoring
(1) (intelligent OR smart OR monitor) AND packaging
AND temperature
(2) (intelligent OR smart OR monitor) AND packaging
AND (humidity OR moisture)
(3) (light OR optical OR UV) AND food AND packaging
(4) packaging AND contamination
(5) (vibration OR shock OR acceleration OR shake OR
agitation) AND packaging
(6) (report OR monitor OR detection) AND expiry
Safety (1) tamper-proof packaging
(2) anti-counterfeit
(3) track & trace collecting and dispensing
system
(4) errors tracking from patients and
pharmacists
(1) (evident OR resistant OR detection OR proof) AND
tamper AND packaging
(2 - 4) (pharmaceutical OR intelligent OR smart OR
packaging) AND counterfeit
The scope of the current study is limited to the technologies applicable to meeting the quality and
safety requirements which are common to all involved stakeholders. However, a brief discussion on
how other requirements are tackled can be found in Section 4. Searching of technologies relies on the
keywords derived from the requirements through a selection of popular search engines which provide
comprehensive listings of journal articles from engineering, pharmacy, medical and psychological
sciences. As the purpose of this survey is to lay down the groundwork for deeper systematic review
of individual technologies that are appropriate for medicine reuse, the searching formulas were
restricted to the titles of papers enabling a preliminary study of latest technologies on recycling
medicines. Synonyms for keywords were used to expand the search to a wider area of study; however,
the term “pharmaceutical” is not used in some formulas due to the fact that technological research
on pharmaceutical packaging is not yet a major research topic for certain technologies. A zero result
was obtained in many rounds of keyword searches when the term “pharmaceutical packaging” was in
place, so the term was finally removed in some of the search formulas. The five chosen search engines
for finding the literature in the present study are: Google scholar (https://scholar.google.com/),
Scopus (https://www.scopus.com/), IEEE Xplorer digital library (https://ieeexplore.ieee.org/Xplore/
home.jsp), Web of Science (https://wok.mimas.ac.uk/), and Pubmed (https://www.ncbi.nlm.nih.
gov/pubmed/).
PRISMA flow was followed for screening and selecting the articles to be further studied in this
paper, and Figure 1 depicts the selection process flow. The numbers of chosen articles for each process
are also illustrated in the flow chart. Other than those academic papers retrieved from the search
engines mentioned above, handpicked articles were also collected mainly based on the citations from
the collected papers.
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Figure 1. PRISMA [36] flow for screening literature (articles collected are classified into Quality and
Safety requirements)
3. Results
The results of literature review show that the technologies, especially those embedded in
pharmaceutical packaging, for reusing medicines returned from patients are still largely ignored
by mainstream academic research. Legal issues could be one reason, but the lack of technologies to
enable a comprehensive validation of the quality and safety of returned medicines may also be a big
obstacle. Law makers, as well as other stakeholders in society, may be skeptical about re-dispensing
returned medicines without proper validation [16]. This section describes how latest technologies
collected from the literature review can enable the reuse of returned medicines according to the two
groups of stakeholder requirements for quality and safety listed in Table 2.
Intelligent packaging has been a major research topic in the food industry and many of its
technologies can also be applied in pharmaceutical packaging. The literature review suggests that
the main purpose for intelligent food packaging focuses on monitoring the freshness of the food
content rather than observing the storage condition of the medicines in pharmaceutical packaging [40].
Deterioration of the packaged food is basically the major concern in the food industry. Müller
and Schmid [33] proposes that (i) environmental conditions, (ii) quality characteristics or quality
indicator compounds, and (iii) data carriers are the three major concepts in intelligent food packaging.
Application of technologies to these concepts, especially the environmental condition monitoring, is
closely resembled to the pharmaceutical counterpart where the sensors are measuring the surroundings
of pharmaceutical packaging rather than the space inside food packaging. Sensing technologies based
on chemical, biological or physical sensors are the core components in intelligent food packaging
enabling passive or active indications of the status of the packaged food to consumers [40,41].
Collection of articles was first focused on technologies applying directly to pharmaceutical packaging,
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but those that applied to food packaging were also chosen in this study when no relevant article was
found in the pharmaceutical sector.
Before achieving economies of scale, the high cost of implementation in intelligent pharmaceutical
packaging could restrict the application to high priced medicines. However, recycling of the packaging
materials has become a trend in protecting the environment and reducing the overall costs in adding
technological ingredients into smart packaging [42], thus, the integration of relatively high cost
components can be justified.
3.1. Technologies for Quality Requirements
Sensors play a crucial part in pharmaceutical packaging for quality assurance of dispensed
medicines. The requirements in Table 1 suggest the major quality indicators which detect and
report the real-time status of the medicines. Indications include the storage environment (e.g.,
temperature, humidity, lighting), the handling methods (e.g., contamination, agitation, motion),
and the expiration date.
Time–temperature indicators (TTI) are the most popular attachment to an intelligent package
reporting the history of the temperature variation for a certain period of time [43]. Specific
technologies contribute to the different implementation of the TTI sensing devices with various
time scales and sensing technologies for detecting temperature of the storage environment [44]
as well as the contents [45]. However, the physical indication of the TTI devices normally
requires human intervention through visual inspection. Computer vision based on computational
intelligence can replace the human judgment for TTI result recognition but a complicated setup is
needed. Mijanur Rahman et al. [46] enhanced the TTI concept using biosensors enabling the detection
of the sensing results through a digital interface.
Thin-film technologies through printed electronics or nanotechnology further improve the
integration of the pharmaceutical packaging with information technology (IT). Quality assurance
indication for the real-time storage conditions can then be shared with all connected stakeholders.
Printed electronics allow key sensors such as temperature, humidity and ambient light to be printed on
paper or plastic foil. Together with a printed RFID tag, an IT connected storage sensing structure can
be built on pharmaceutical packaging [47–50]. Processing power for performing complicated logical
operations is possible by combining prebuilt electronic modules (e.g., microprocessor, other sensors not
available yet in printed electronics, etc.) with printed circuits through the hybrid printed electronics
methodology [51,52]. Nanotechnology strengthens the thin-film technologies through depositing
carbon nanotubes onto the packaging materials and further enhances the manufacturing time and
increases the functionality of the embedded electronics for quality monitoring of medicines [53–55].
Contamination detection of the medicines inside the packaging is not trivial. Johnston et al. [56]
suggested the usage of PT/GC/MS (Purge and Trap/Gas Chromatography/Mass Spectrometry)
methods for detecting smoke contaminated packages, while Mielniczuk and Pogorzelska [57] used
GC/MS to examine the microbial contaminants. Both proved to be effective, but they are not
field-applicable since portable PT/GC/MS machines are not yet generally available. Computer vision
could be an alternative for visual inspection of microbial contamination, perhaps under ultraviolet
light. However, the resolution for handheld cameras such as those in smartphones may need to be
upgraded allowing the general public to conveniently capture and analyze the small particle size
of contaminants [58]. An indirect method suggested for identifying potential contamination was to
look for visible damage on the packaging [59,60]. Thus, tamper-proof packaging can act as indirect
protection from contamination.
Agitation and vibration of the pharmaceutical packaging may affect some medicines, such
as insulin [61]. Monitoring of unexpected motions during transportation and storage is therefore
necessary to validate the quality for specific types of medicines [62]. The literature search suggests
that motion sensing for agitation or spinning applying particularly to pharmaceutical packaging is not
being used. No article was found according to the formulas defined in Section 2. However, wearable
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motion sensors are an emerging topic undergoing extensive research in the personal healthcare sector.
Many of them measuring human activities according to variations of the different axis of acceleration or
direction can be applied to pharmaceutical packaging as long as they can be flexibly and unnoticeably
attached to the packaging materials using thin-film technologies [63,64].
Artificial intelligence combined with image processing enables recognition of the expiry
date. Gong et al. [65] illustrated the detection of expiration date on the packaging through a deep
neural network, and Peng et al. [66] applied an enhanced “efficient subwindow search” algorithm to
locate and recognize the expiry date details from an image of the packaging. QR (quick response) codes
combined with SMS (short message service) can be an alternative but a smartphone is required and a
predefined standard for QR codes becomes necessary [67]. A dynamic display on the pharmaceutical
packaging showing all details of the medicines will be a better way to show all updated information
to the patients, and an e-ink (electronic ink) display will be a good low-power (zero power when
the display content is stable) method acting as a real-time visual indicator on the pharmaceutical
packaging [68]. The flexible e-ink display not only shows the updated information of the medicine
inside the packaging, a microprocessor driving the display can also report a real-time quality status
according to the sensing results. An electrochromic (EC) display further improves the relatively
high-power refresh cycles in e-ink technology during screen content update, and provides a promising
alternative for printing a low-power thin-film dynamic display on paper [69,70].
3.2. Technologies for Safety Requirements
Safety of medicines is the next critical concern in the reuse process. Even if the returned
medicines are quality assured through the technologies mentioned in the previous section, two
safety requirements from the stakeholders must be met before medicines could be re-dispensed:
tamper-proofing and anti-counterfeiting (see Table 1 for details). Tamper-evident technologies
provide indications of whether medicines have been used or adulterated, and counterfeit protection
technologies supply methods for authentication.
Tamper-evident pharmaceutical packaging is a mature concept now after the Tylenol tragedy in
1982 where seven patients died due to the intentional adulteration of the medicine [71]. Government
regulations enforced the pharmaceutical industry after the incident to implement appropriate
tamper-evident and tamper-resistant technologies particularly on pharmaceutical packaging protecting
medicines from adulteration [72]. Since then, popular tamper-evident technologies have given
indications on broken sealing of the packaging through (i) film wrapping; (ii) blister or strip packs;
(iii) sealed pouches and sachets; (iv) tape seals; (v) bubble packs; (vi) heat shrink bands or wrappers;
(vii) container mouth seals; (viii) breakable caps; (ix) tear-away caps; (x) sealed metal tubes; and (xi)
laminated tubes [73]. Tamper-evident applies also to the external packaging during transportation
using RFID embedded film wrap which prevents tampering for the whole pallet of medicines [74].
Tamper-proof packaging must be strong enough to prevent accidental breaking; however, also easy
enough to use [75]. To enhance the manufacturability of tamper-proof pharmaceutical packaging in
the factories, blow fill seal [23] and IML (in-mold lamination) [76] provide better ways to integrate
the tamper-evident sealing into the medicine production process in a single flow but the cost may
be higher.
Electronic interfaces allow tamper-proof technologies to be extended to the digital world for
automatic recognition of intentional and unintentional tampering. Digital electronics interacting with
tamper-evident technologies are still at an early stage, and research examples can be found in relation
to blister packs which are the most popular pharmaceutical packaging for tablets by attaching an
aluminum film on top of a thermoformed plastic tray [77]. Floerkemeier and Siegemund [78] illustrated
the addition of a conductive wire matrix on top of the blister pack where the wires were broken when
an individual medicine was removed. The broken wires then activated the built-in communication
module to send a message to the patient’s smartphone or a web server registering the usage status
of the medicines. This technology is applied to track medication adherence but it can also be used in
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tamper-proofing. A more advanced tamper-proof solution was demonstrated by Gao et al. [79] who
used a controlled delamination material (CDM) as a sealing layer covering the medicines. This CDM
layer can be delaminated through activation by electrical power controlled by an RFID tag.
Tamper-proof technologies prevent the pharmaceutical packaging from malicious physical
attacks, and also provide indications for potential contamination of the medicines. However,
a tamper-evident sealing mechanism will not protect patients from falsified medicines whereas
anti-counterfeit technologies can help fight against counterfeiting. Anti-counterfeiting relies on sharing
information between suppliers, customers and governments where unique, traceable and unmodifiable
identity of individual medicines must be shared on a single platform [80]. Overt technologies, such as
holograms and color-shifting paints, usually apply to packaging surfaces allowing trained examiners
or even consumers to do visual anti-counterfeiting authentication. These technologies, however,
are easily replicated and normally do not last for long. Alternatively, covert technologies such as
security taggants and micro-imaging, are basically invisible to naked eyes and require additional
tools for examination. Therefore, authentication by normal consumers on covert anti-counterfeiting
technologies are restricted. A combination of overt and covert methodologies have been adopted in
pharmaceutical packaging to enhance the counterfeit protection strategy from outside of the packaging
down to the surface of the medicine, or even inside the individual medicine [81,82].
Anti-counterfeiting technologies can be applied to the packaging materials. Different types of
spectroscopy methods, such as Fourier Transform Infrared (FT-IR) or Near Infrared (NIR) spectroscopy
can be used to examine the texture of the packaging materials to authenticate the medicine identity [83].
The use of mathematical modeling using discrete Fourier transforms is also possible to perform the
authentication by analyzing the texture of the packaging material through an image [84]. Simske
et al. [85] proposed a fully variable data printing method applying inks with different visibility under
various light spectrums to reject counterfeit medicines.
Tagging technology applicable to anti-counterfeiting has evolved by adding micro-scale taggants
directly onto medicines, especially those in the form of tablets or capsules. Printings on the irregular
surfaces of the tablets combined with the random minor alignment differences create fingerprints
for an individual tag associated with each tablet. A database of these fingerprints can be used as an
authentication tool [86]. A biodegradable micro-scale QR code label was proposed by Fei and Liu [87]
where the label was attached to the tablet with the code being readable by a smartphone. The QR code
can also be debossed on the tablet’s surface through a laser but the depth and the surface materials may
affect the reading sensitivity [88]. A microtaggant technology further enhances tagging techniques by
using micro-meter scale polymer microbeads with QR tags for on-dose authentication [89]. Reading of
the tags may be a destructive process if the reader needs to examine the code on individual tablets,
thus, a better reading method should be used for non-destructive examination. Raman spectroscopy
provides a non-invasive alternative allowing the recognition of the tags even from the outside of the
pharmaceutical packaging [90–92].
A proper track and trace system of the medicines from manufacturers to the patients, or multiple
patients in case of medicine reuse, is a better way to protect from counterfeiting. A call-in numeric
token printed on the packaging can be used to register the medicine once it is used the first time [93],
but this method may not help authenticate a reused medicine. Al-Bahri et al. [94] proposed a complete
track and trace system based on a central server on the Internet allowing each medicine to be treated
as a digital object with unique identity. This DOA (digital object architecture) realizes a shared
platform for all stakeholders to retrieve dedicated information when enough cybersecurity is properly
implemented. The open and distributed ledger process of blockchain technology enables tracking of
medicines registering every transaction among manufacturers, suppliers, pharmacists and patients.
The open ledger blockchain can also register the multiple recycling actions between patients [95–97].
The Falsified Medicines Directives (FMD) [98] operating in Europe since February 2019 may force
the implementation of anti-counterfeiting on pharmaceutical packaging through the addition of QR
Pharmacy 2020, 8, 58 10 of 18
codes and tamper-proof sealing. However, the certification system may need to be adjusted to fit for a
re-dispensing process for medicines reuse.
4. Discussion
Technologies for tackling quality and safety requirements can be found from contemporary
research but most of them are passive in nature where interaction of medicines with the digital world
is missing. The literature review in Section 3 is summarized in Table 3 illustrating a taxonomy
of technologies classified according to individual applications and stakeholders’ requirements.
Sharing real-time information about medicines between stakeholders is important to maintain a
complete medicine reuse system. Storage conditions can be digitally sensed, reported and analyzed
dynamically through embedded microprocessors or via cloud computing services. A decision for
returning and re-dispensing can be displayed directly on the packaging or indirectly through the
smartphone or any surrounding smart devices. A judgment on re-dispensing returned medicines
relies on a safety authentication process where the validation of unopened, undamaged and genuine
medicines can be performed at pharmacies using dedicated analyzers. Active technologies together
with network connectivity empower smart pharmaceutical packaging for the reuse of returned,
unused, and unexpired medicines. IoT provides such a platform for sharing information of the
medicines through the Internet for every stakeholder, and the concept of a smart object comprising a
pharmaceutical packaging with the medicines inside acts as an IoT edge device with digital sensing and
network connection [99]. A cloud computing service enables the exchange of information between the
smart devices and the stakeholders through wearables, smartphones or full featured computers [100].
Table 3. Latest technologies for reusing returned medicines.
Requirements Technologies
Quality (i) storage temperature monitoring: passive TTI [43–45]
(ii) storage temperature monitoring: active TTI with digital interfaces [46]
(iii) thin-film technology: printed sensors and RFID tags [47–50]
(iv) thin-film technology: hybrid printed circuits [51,52]
(v) thin-film technology: nanotechnology [53–55]
(vi) contamination detection: PT/GC/MS methodology [56,57]
(vii) contamination detection: computer vision [58]
(viii) contamination detection: tamper-evident check [59,60]
(ix) motion detection: wearable sensors [63,64]
(x) expiry date detection: visual inspection [66]
(xi) expiry date detection: QR codes and smartphones [67]
(xii) on packaging display: e-ink displays [68] and EC displays [69,70]
Safety (i) tamper-proof: tamper-evident and tamper-resistance on packaging [71–73,75]
(ii) tamper-proof: tamper-evident for transportation [74]
(iii) tamper-proof: implementation during production [23,76]
(iv) tamper-proof: built-in digital interfaces [77,78]
(v) anti-counterfeit: overt/covert indications [80–82]
(vi) anti-counterfeit: packaging materials inspection [83–85]
(vii) anti-counterfeit: tagging on label, on medicine and on-dose [86–89]
(viii) anti-counterfeit: readers for mini-size tags [90–92]
(ix) anti-counterfeit: track and trace systems through Internet [93,94]
(x) anti-counterfeit: open ledger based on blockchain [95–97]
A similar structure to that discussed above can be found in a smart medicine box which is an
emerging research topic integrating digital sensors and networking capability so that they can monitor
normal medicines put inside the box. Additional technologies can be applied to the surroundings of
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the smart medicine box as well for facilitating an electronic reminder for medication adherence [101],
an in-house track and trace system [102], or an interaction with remote servers for telehealthcare [103,104].
Embedding IoT technologies into pharmaceutical packaging allows normal packages of medicines to
become intelligent packaging [105–107], thus, the requirements for reusing medicines are met where an
extension of the real-time information to cloud computing empowers all stakeholders to share data on
a single platform. However, three other critical technologies may need to be further investigated to
realize an intelligent pharmaceutical packaging for medicines reuse:
(i) Thin-film technologies
Printed electronics and nanotechnology mentioned previously provide methods to place electronic
circuits on packaging materials. However, these technologies are still not common and
complicated circuitry such as wireless modules and high-power microprocessors are still not
directly printable onto the packaging surface.
(ii) Energy harvesting
RFID is normally used to provide power to read a passive tag but a continuous power supply
for maintaining the regular sensing and the network connection is required. Technology for
printed batteries is still in an early stage [108], energy harvesting techniques such as extracting
ambient energy could be an alternative [109], and wireless charging can also be a good candidate
supplying continuous power to the embedded electronics from a distance [110]. However, all
these technologies are not yet mature enough for immediate implementation onto intelligent
pharmaceutical packaging.
(iii) Flexible display
Flexible displays using e-ink or EC technology show a promising way to use minimum energy to
sustain a dynamic changing electronic display mounted on existing flat or curved pharmaceutical
packaging. Although no power is required for maintaining e-ink screen contents, the irregular
updates still require a significant amount of electrical power to align the color pigments.
Electrochromism technology reduces the energy for updating EC displays but a regular refresh
process is required to keep the screen content visible. New low cost, low energy and printable
technologies for pharmaceutical packaging are required.
Other than the two main groups of requirements discussed in Section 3, there are other concerns
from the stakeholders in Table 1 to be resolved before an action for reusing medicines can be taken,
and they are summarized as below:
(a) patients’ incentive for returning unwanted medicines,
(b) pharmacists’ incentive for extra workload in re-dispensing medicines,
(c) cost effectiveness monitoring of reusing medicines,
(d) legal issues such as legislation on re-dispensing medicines and professional standards for
pharmacists,
(e) social norm for promoting medicine reuse,
(f) on-site and off-site collection and distribution system.
Items (a) to (e) are not directly related to technology. However, technologies may help quantify
the data (e.g., immediate cost saving for recycling certain medicines, calculation and distribution of
incentives to related stakeholders, etc.) or support information exchange in a social networks on the
Internet. Social networking may also gather supporting power to influence government decisions
on changing policies. Item (f) may make use of the IoT platform to collect, register, authenticate and
re-dispense using a proven track and trace system through the IoT networks.
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5. ReMINDS ecosystem
Based on the qualitative research within pharmacy practice and the concept of technology
integration for pharmaceutical packaging, a group called ReMINDS (Reuse of Medicines through
Informatics, Networks and Sensors) has recently been established in the University of Reading with
the aim of promoting the reuse of medicines in the UK. ReMINDS is driven by a multidisciplinary
team with members coming from pharmacy, computer science and biomedical engineering.
The reuse of medicines is not purely a technical issue since (i) it creates legal concerns involving
changes in policies by governments, (ii) it affects commercial decisions involving changes in financial
performance for pharmaceutical companies, (iii) it requires voluntary actions involving changes in
patient behaviors through patient beliefs, and (iv) it increases extra workloads and risks involving
changes in the code of conduct for pharmacists. Previous research suggests that every stakeholder
in society contributes part of the responsibility to recycle returned and unused medicines where an
ecosystem is apparently established by itself. A novel ReMINDS ecosystem for reusing dispensed
medicines through a technology perspective is proposed and Figure 2 depicts the relationship between
each party in the hypothesized ecosystem for medicine reuse. The concept of ReMINDS ecosystem can
be one of the solutions for reusing dispensed medicines and reducing medicinal waste, and it is built
on top of the IoT where seamless connections between medicines and the related stakeholders is the
key for success.
Figure 2. An ecosystem for the reuse of medicines from a technology perspective.
Patients and pharmacists are not the only groups in society responsible for taking actions in
returning and re-dispensing medicines, other stakeholders in society as a whole play different but
crucial roles in maintaining a sustainable ecosystem for reusing medicines. Patients may be the
first decision maker to return unused medicines back to the recycle centers, and technologies can
provide indications for when and where the medicines are reused or disposed. Pharmacists accept and
examine the returned medicines, and technologies enable them to validate the usable conditions before
re-dispensing. Raw data of the types, quantity and quality of returned medicines are uploaded to a
cloud server empowering an off-site analysis, different entities can retrieve information using various
analytical methods. Doctors and healthcare professionals write the prescriptions to the patients but
they may not be directly involved in the whole return and re-dispense process; however, technologies
allow them to investigate the therapeutic effectiveness based on the information collected and analyzed
through cloud computing. Pharmaceutical companies provide standards to pharmacists for validation
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of the usable conditions for returned medicines, for examples, the duration and limits for out-of-range
storage temperature or humidity. Government is a key stakeholder who can set or change the policies
enabling and governing related activities, the lawmakers may require specific information from the
cloud server to monitor and adjust the execution of policies. As well as playing a role in returning
unused medicines, the general public also act as a supporting role through online social networks by
influencing the government and establishing a norm for the recycling of medicines.
6. Conclusions
A literature survey of latest technologies facilitating the design of intelligent pharmaceutical
packaging for reusing medicines is reported. A taxonomy of the reviewed technologies is suggested
according to the requirements for shaping human behaviors to take appropriate actions. Through a
technology perspective, a novel ReMINDS ecosystem as a suggested solution for reusing returned
prescribed medicines based on the literature review is proposed. Active sensing technologies integrated
with the IoT platform indicate how a combination of informatics, networks and digital sensors facilitate
society to make possible the reuse of medicines.
Technologies provide the tools to directly or indirectly meet the various requirements from each
stakeholder. Embedded sensing and reporting electronics on the pharmaceutical packaging help
validate the quality and safety of the medicines. Network connectivity helps connect the intelligent
packaging globally to all stakeholders in the ReMINDS ecosystem. However, intelligent packaging for
reusing medicines is still not mainstream research and more studies in thin-film technologies, energy
harvesting, flexible low-power display are essential to empower the technologies on pharmaceutical
packaging to become the key enabler for reusing returned prescribed medicines and reducing medicinal
waste. Further research on developing and applying appropriate technologies onto and around the
pharmaceutical packaging for establishing the hypothesized ReMINDS ecosystem will be one of the
aims for the ReMINDS team.
Author Contributions: T.K.L.H. conceived and conducted the literature review and prepared the manuscript.
B.M. prepared the initial article, reviewed and revised the manuscript. P.D. critically reviewed and revised the
manuscript from a pharmaceutical perspective. R.M. critically reviewed and revised the manuscript from an
informatics perspective. R.S.S. critically reviewed and revised the manuscript from a biomedical engineering
perspective and funding acquisition. All authors have read and agreed to the published version of the manuscript.
Funding: This research was funded through the University of Reading Research Endowment Trust Fund (RETF),
the Building Outstanding Impact Support Programme (BOISP), and an EPSRC summer studentship.
Conflicts of Interest: All authors declare no conflict of interest.
References
1. Hazell, B.; Robson, R. Pharmaceutical waste reduction in the NHS. Rep. Version 2015, 1, 1–24.
2. Opar, A. Rising drug costs prompt new uses for old pills. Nat. Med. 2006, 12, 1333.
3. Toh, M.R.; Chew, L. Turning waste medicines to cost savings: A pilot study on the feasibility of medication
recycling as a solution to drug wastage. Palliat. Med. 2017, 31, 35–41, doi:10.1177/0269216316639798.
4. Bekker, C.L.; Gardarsdottir, H.; Egberts, A.C.G.; Molenaar, H.A.; Bouvy, M.L.; van den Bemt, B.J.F.; Hövels, A.M.
What does it cost to redispense unused medications in the pharmacy? A micro-costing study. BMC Health Serv. Res.
2019, 19, 243, doi:10.1186/s12913-019-4065-6.
5. Trueman, P.; Taylor, D.; Lowson, K.; Bligh, A.; Meszaros, A.; Wright, D.; Glanville, J.; Newbould, J.;
Bury, M.; Barber, N.; Jani, Y. Evaluation of the Scale, Causes and Costs of Waste Medicines; Technical report;
DH funded national project, 2010.
6. Bekker, C.; Gardarsdottir, H.; Egberts, A.; Bouvy, M.; van den Bemt, B. Worldwide initiatives to decrease
medication wastage: a cross-national survey. In Proceedings of the 44th ESCP International Symposium
on Clinical Pharmacy Medicines Information: Making Better Decisions, Lisbon, Portugal, 30 October 2015;
Volume 38, p. 591.
7. Connelly, D. Should pharmacists be allowed to reuse medicines. Pharm. J. 2019, doi:10.1211/PJ.2018.20205091.
Pharmacy 2020, 8, 58 14 of 18
8. Kaldy, J. Program Turns Discarded Drugs Into Lifesavers for Needy. Caring Ages 2015, 16, 9,
doi:10.1016/j.carage.2015.07.012.
9. Cauchi, R.; Berg, K. State Prescription Drug Return, Reuse and Recycling Laws. Available
online: http://www.ncsl.org/research/health/state-prescription-drug-return-reuse-and-recycling.aspx
(accessed on 10 November 2019).
10. Crews, J. Prescription Drug Reuse and Recycling; Taylor & Francis: Abingdon, UK, 2019,
doi:10.1080/10463356.2019.1656001.
11. WHO. Guidelines for Drug Donations; World Health Organization: Geneva, Switzerlnad, 1999; Volume 20.
12. Gotink, M.H.; Ralitapole, D.K. Inter Care: help for rural African hospitals. Br. Med J. 1988, 297, 1402.
13. Viegas, C.V.; Bond, A.; Vaz, C.R.; Bertolo, R.J. Reverse flows within the pharmaceutical supply chain:
A classificatory review from the perspective of end-of-use and end-of-life medicines. J. Clean. Prod.
2019, 238, 117719, doi:10.1016/j.jclepro.2019.117719.
14. Trappey, A.J.C.; Trappey, C.V.; Fan, C.Y.; Hsu, A.P.T.; Li, X.K.; Lee, I.J.Y. IoT patent roadmap for
smart logistic service provision in the context of Industry 4.0. J. Chin. Inst. Eng. 2017, 40, 593–602,
doi:10.1080/02533839.2017.1362325.
15. Ding, B. Pharma Industry 4.0: Literature review and research opportunities in sustainable pharmaceutical
supply chains. Process. Saf. Environ. Prot. 2018, 119, 115–130, doi:10.1016/j.psep.2018.06.031.
16. Bekker, C.L.; Gardarsdottir, H.; Egberts, T.C.G.; Bouvy, M.L.; van den Bemt, B.J.F. Redispensing of
medicines unused by patients: a qualitative study among stakeholders. Int. J. Clin. Pharm. 2017, 39, 196–204,
doi:10.1007/s11096-017-0424-8.
17. Bekker, C.; van den Bemt, B.; Egberts, T.C.G.; Bouvy, M.; Gardarsdottir, H. Willingness of patients to use
unused medication returned to the pharmacy by another patient: a cross-sectional survey. BMJ Open
2019, 9, 1–5.
18. McRae, D.; Allman, M.; James, D. The redistribution of medicines: could it become a reality? Int. J. Pharm. Pract.
2016, 24, 411–418, doi:10.1111/ijpp.12275.
19. Alhamad, H.; Patel, N.; Donyai, P. How do people conceptualise the reuse of medicines? An interview
study. Int. J. Pharm. Pract. 2018, 26, 232–241, doi:10.1111/ijpp.12391.
20. Black, G. Reuse of medicine: it’s not about the money!: from my Little Black Book of pharmacy practice:
practice matters. SA Pharm. J. 2011, 78, 51–53.
21. Lorenzini, G.C.; Mostaghel, R.; Hellstrom, D. Drivers of pharmaceutical packaging innovation: A
customer-supplier relationship case study. J. Bus. Res. 2018, 88, 363–370, doi:10.1016/j.jbusres.2017.11.030.
22. Munzel, J. Pharmaceutical packaging: Technology and design requirements are on the rise. J. Med Mark.
2007, 7, 136–145, doi:10.1057/palgrave.jmm.5050078.
23. Zadbuke, N.; Shahi, S.; Gulecha, B.; Padalkar, A.; Thube, M. Recent trends and future of pharmaceutical
packaging technology. J. Pharm. Bioallied Sci. 2013, 5, 98–110, doi:10.4103/0975-7406.111820.
24. Sehgal, S.; Jaithliya, T.; Khan, M.; Devi, A.N.; Banoo, J.; Tiwari, A. Recent trends and future of
pharmaceutical packaging technology: an overview. Eur. J. Biomed. Pharm. Sci. 2018, 5, 957–966.
25. Madhusudan, P.; Chellukuri, N.; Shivakumar, N. Smart packaging of food for the 21st century—A review
with futuristic trends, their feasibility and economics. Mater. Today Proc. 2018, 5, 21018–21022,
doi:10.1016/j.matpr.2018.06.494.
26. Hara, L.; Guirguis, R.; Hummel, K.; Villanueva, M. More Than Bar Codes: Integrating Global
Standards-Based Bar Code Technology Into National Health Information Systems in Ethiopia and
Pakistan to Increase End-to-End Supply Chain Visibility. Glob. Health Sci. Pract. 2017, 5, 678–685,
doi:10.9745/Ghsp-D-16-00350.
27. Lavorgna, A. The online trade in counterfeit pharmaceuticals: new criminal opportunities, trends and
challenges. Eur. J. Criminol. 2015, 12, 226–241, doi:10.1177/1477370814554722.
28. Degardin, K.; Guillemain, A.; Klespe, P.; Hindelang, F.; Zurbach, R.; Roggo, Y. Packaging analysis of
counterfeit medicines. Forensic Sci. Int. 2018, 291, 144–157, doi:10.1016/j.forsciint.2018.08.023.
29. Patel, R.P.; Patel, Y.B.; Prajapati, B.G.; Borkhataria, C.H. Outline of Pharmaceutical Packaging Technology.
Int. Res. J. Pharm. 2010, 1, 105–112.
30. Janjarasskul, T.; Suppakul, P. Active and intelligent packaging: The indication of quality and safety.
Crit. Rev. Food Sci. Nutr. 2018, 58, 808–831, doi:10.1080/10408398.2016.1225278.
Pharmacy 2020, 8, 58 15 of 18
31. Selman, J.D. Time-temperature indicators. In Active Food Packaging; Springer US: Boston, MA, USA, 1995;
pp. 215–237, doi:10.1007/978-1-4615-2175-4_10.
32. Usak, M.; Kubiatko, M.; Shabbir, M.S.; Viktorovna Dudnik, O.; Jermsittiparsert, K.; Rajabion, L. Health
care service delivery based on the Internet of things: A systematic and comprehensive study. Int. J.
Commun. Syst. 2020, 33, e4179, doi:10.1002/dac.4179.
33. Müller, P.; Schmid, M. Intelligent packaging in the food sector: a brief overview. Foods 2019, 8, 16,
doi:10.3390/foods8010016.
34. Kleppe, M.; Lacroix, J.; Ham, J.; Midden, C. A dual-process view on medication adherence: The role of
affect. J. Health Psychol. 2017, 24, 1033–1042, doi:10.1177/1359105317690599.
35. Martin, L.R.; Feig, C.; Maksoudian, C.R.; Wysong, K.; Faasse, K. A perspective on nonadherence to
drug therapy: psychological barriers and strategies to overcome nonadherence. Patient Prefer. Adherence
2018, 12, 1527–1535, doi:10.2147/PPA.S155971.
36. Swartz, M.K. The PRISMA Statement: A Guideline for Systematic Reviews and Meta-Analyses. J. Pediatr.
Health Care 2011, 25, 1–2, doi:10.1016/j.pedhc.2010.09.006.
37. Waffenschmidt, S.; Knelangen, M.; Sieben, W.; Bühn, S.; Pieper, D. Single screening versus conventional
double screening for study selection in systematic reviews: a methodological systematic review. BMC Med.
Res. Methodol. 2019, 19, 132, doi:10.1186/s12874-019-0782-0.
38. Munn, Z.; Peters, M.D.J.; Stern, C.; Tufanaru, C.; McArthur, A.; Aromataris, E. Systematic review or
scoping review? Guidance for authors when choosing between a systematic or scoping review approach.
BMC Med. Res. Methodol. 2018, 18, 143, doi:10.1186/s12874-018-0611-x.
39. Hubley, J. Understanding Behaviour: The Key to Successful Health Education. Trop. Dr. 1988, 18, 134–138,
doi:10.1177/004947558801800316.
40. Yousefi, H.; Su, H.M.; Imani, S.M.; Alkhaldi, K.; M. Filipe, C.D.; Didar, T.F. Intelligent Food Packaging:
A Review of Smart Sensing Technologies for Monitoring Food Quality. ACS Sensors 2019, 4, 808–821,
doi:10.1021/acssensors.9b00440.
41. Kuswandi, B.; Wicaksono, Y.; Jayus.; Abdullah, A.; Lee, Y.H.; Ahmad, M. Smart Packaging: Sensors
for monitoring of food quality and safety. Sens. Instrum. Food Qual. Saf. 2011, 5, 137–146,
doi:10.1007/s11694-011-9120-x.
42. Vanderroost, M.; Ragaert, P.; Devlieghere, F.; De Meulenaer, B. Intelligent food packaging: The next
generation. Trends Food Sci. Technol. 2014, 39, 47–62, doi:10.1016/j.tifs.2014.06.009.
43. Pavelková, A. Time temperature indicators as devices intelligent packaging. ACTA Univ. Agric. Silvic.
Mendel. Brun. 2013, 61, 245–251, doi:10.11118/actaun201361010245.
44. Wang, S.; Liu, X.; Yang, M.; Zhang, Y.; Xiang, K.; Tang, R. Review of Time Temperature Indicators as
Quality Monitors in Food Packaging. Packag. Technol. Sci. 2015, 28, 839–867, doi:10.1002/pts.2148.
45. Pereira Jr., V.A.; de Arruda, I.N.Q.; Stefani, R. Active chitosan/PVA films with anthocyanins from Brassica
oleraceae (Red Cabbage) as Time-Temperature Indicators for application in intelligent food packaging.
Food Hydrocoll. 2015, 43, 180–188, doi:10.1016/j.foodhyd.2014.05.014.
46. Mijanur Rahman, A.T.M.; Kim, D.H.; Jang, H.D.; Yang, J.H.; Lee, S.J. Preliminary study on biosensor-type
time-temperature integrator for intelligent food packaging. Sensors 2018, 18, 1949, doi:10.3390/s18061949.
47. Maslik, J.; Andersson, H.; Forsberg, V.; Engholm, M.; Zhang, R.; Olin, H. PEDOT: PSS temperature sensor
ink-jet printed on paper substrate. J. Instrum. 2018, 13, C12010, doi:10.1088/1748-0221/13/12/C12010.
48. Maiellaro, G.; Ragonese, E.; Gwoziecki, R.; Jacobs, S.; Marjanovic´, N.; Chrapa, M.; Schleuniger, J.; Palmisano,
G. Ambient light organic sensor in a printed complementary organic TFT technology on flexible plastic
foil. IEEE Trans. Circuits Syst. Regul. Pap. 2013, 61, 1036–1043, doi:10.1109/TCSI.2013.2286031.
49. Feng, Y.; Xie, L.; Chen, Q.; Zheng, L. Low-Cost Printed Chipless RFID Humidity Sensor Tag for Intelligent
Packaging. IEEE Sensors J. 2015, 15, 3201–3208, doi:10.1109/JSEN.2014.2385154.
50. Javed, N.; Habib, A.; Amin, Y.; Loo, J.; Akram, A.; Tenhunen, H. Directly Printable Moisture Sensor Tag for
Intelligent Packaging. IEEE Sensors J. 2016, 16, 6147–6148, doi:10.1109/JSEN.2016.2582847.
51. Zhang, X.; Shan, X.; Wei, J. Hybrid flexible smart temperature tag with NFC technology for smart packaging.
In Proceedings of the 19th Electronics Packaging Technology Conference, Singapore, 6 December 2017;
pp. 1–5, doi:10.1109/eptc.2017.8277578.
52. Falco, A.; Salmerón, J.F.; Loghin, F.C.; Lugli, P.; Rivadeneyra, A. Fully printed flexible single-chip RFID tag
with light detection capabilities. Sensors 2017, 17, 534, doi:10.3390/s17030534.
Pharmacy 2020, 8, 58 16 of 18
53. Kuswandi, B., Nanotechnology in Food Packaging. In Nanoscience in Food and Agriculture; Springer:
Berlin/Heidelberg, Germany, 2016; pp. 151–183, doi:10.1007/978-3-319-39303-2_6.
54. Feng, Y.; Xie, L.; Mäntysalo, M.; Chen, Q.; Zheng, L. Electrical and humidity-sensing characterization of inkjetprinted
multi-walled carbon nanotubes for smart packaging. Sensors IEEE 2013, 1–4, doi:10.1109/ICSENS.2013.6688306.
55. Rahimi, R.; Zhou, J.; Jiang, H.; Soleimani, T.; Ziaia, B. Facile fabrication of low-cost passive wireless
humidity sensor for smart packaging via all-laser processing of metalized paper. In Proceedings of
the Solid-State Sensors, Actuators and Microsystems Workshop, Hilton Head Island, SC, USA, 2018;
pp. 326–329, doi:10.31438/trf.hh2018.92.
56. Johnston, J.J.; Wong, J.P.; Feldman, S.E.; Ilnicki, L.P. Purge and Trap/Gas Chromatography/Mass
Spectrometry Method for Determining Smoke Contamination of Foods and Packaging Materials. J. Agric.
Food Chem. 1994, 42, 1954–1958, doi:10.1021/jf00045a023.
57. Mielniczuk, Z.; Pogorzelska, Z. Detection of microbial contamination of packaging for foodstuffs by gas
chromatography-mass spectrometry method. Packag. Technol. Sci. 2002, 15, 47–51, doi:10.1002/pts.566.
58. Tretola, M.; Di Rosa, A.R.; Tirloni, E.; Ottoboni, M.; Giromini, C.; Leone, F.; Bernardi, C.E.M.; Dell’Orto,
V.; Chiofalo, V.; Pinotti, L. Former food products safety: microbiological quality and computer vision
evaluation of packaging remnants contamination. Food Addit. Contam. Part A 2017, 34, 1427–1435,
doi:10.1080/19440049.2017.1325012.
59. Troja, D.; Shabani, L.; Troja, R. Packaging systems influcnce on the microbial contamination of common
pharmaceutical products. J. Hyg. Eng. Des. 2014, 6, 142–146.
60. White, K.; Lin, L.; Dahl, D.W.; Ritchie, R.J.B. When do consumers avoid imperfections? Superficial
packaging damage as a contamination cue. J. Mark. Res. 2016, 53, 110–123, doi:10.1509/jmr.12.0388.
61. Akbarian, M.; Ghasemi, Y.; Uversky, V.N.; Yousefi, R. Chemical modifications of insulin: Finding a
compromise between stability and pharmaceutical performance. Int. J. Pharm. 2018, 547, 450–468,
doi:10.1016/j.ijpharm.2018.06.023.
62. Hii, M.S.Y.; Courtney, P.; Royall, P.G. An Evaluation of the Delivery of Medicines Using Drones. Drones
2019, 3, 52, doi:10.3390/drones3030052.
63. Jing, Q.; Xie, Y.; Zhu, G.; Han, R.P.S.; Wang, Z.L. Self-powered thin-film motion vector sensor. Nat. Commun.
2015, 6, 8031, doi:10.1038/ncomms9031.
64. Yamamoto, Y.; Harada, S.; Yamamoto, D.; Honda, W.; Arie, T.; Akita, S.; Takei, K. Printed multifunctional
flexible device with an integrated motion sensor for health care monitoring. Sci. Adv. 2016, 2, e1601473,
doi:10.1126/sciadv.1601473.
65. Gong, L.; Yu, M.; Duan, W.; Ye, X.; Gudmundsson, K.; Swainson, M. A Novel Camera Based Approach for
Automatic Expiry Date Detection and Recognition on Food Packages. In Artificial Intelligence Applications
and Innovation. IFIP Advances in Information and Communication Technology; Springer: Cham, Switzerland,
2018; pp. 133–142, doi:10.1007/978-3-319-92007-8_12.
66. Peng, E.; Peursum, P.; Li, L. Product Barcode and Expiry Date Detection for the Visually Impaired Using a
Smartphone. In Proceedings of the International Conference on Digital Image Computing Techniques and
Applications (DICTA), Perth, Australia, 3 Decemebr 2012; pp. 1–7, doi:10.1109/DICTA.2012.6411673.
67. Ramalingam, M.; Puviarasi, R.; Zakaria, N.D.A.B. Developing mobile application for medicine expiry date
detection. Int. J. Pure Appl. Math. 2018, 119, 3895–3900.
68. Blankenbach, K.; Duchemin, P.; Rist, B.; Bogner, D.; Krause, M. Smart Pharmaceutical Packaging with
E-Paper Display for improved Patient Compliance. In SID Symposium Digest of Technical Papers; Wiley:
Hoboken, NJ, USA, 2018; Volume 49, pp. 271–274.
69. Kai, H.; Suda, W.; Ogawa, Y.; Nagamine, K.; Nishizawa, M. Intrinsically Stretchable Electrochromic Display
by a Composite Film of Poly(3,4-ethylenedioxythiophene) and Polyurethane. ACS Appl. Mater. Interfaces
2017, 9, 19513–19518, doi:10.1021/acsami.7b03124.
70. Brooke, R.; Edberg, J.; Crispin, X.; Berggren, M.; Engquist, I.; Jonsson, P.M. Greyscale and Paper
Electrochromic Polymer Displays by UV Patterning. Polymers 2019, 11, doi:10.3390/polym11020267.
71. Kumbhar, M.S.; Choudhary, N.H.; Dighe, D.A.; Singh, M.C. Tamper Evident Pharmaceutical Packaging -
Needs and Advances. Int. J. Pharm. Sci. Rev. Res. 2012, 13, 141–153.
72. CPG. Compliance Policy Guide Sec. 450.500 Tamper-Resistant Packaging Requirements for Certain
Over-the-Counter Human Drug Products MAY 1992; Federal register; US Food and Drug Administration:
Washington, DC, USA, 2015; Volume 63, pp. 59463–59471.
Pharmacy 2020, 8, 58 17 of 18
73. Kumar, A.K.; Gupta, N.V.; Lalasa, P.; Sandhil, S. A review on packaging materials with anti-counterfeit,
tamper-evident features for pharmaceuticals. Int. J. Drug Dev. Res. 2013, 5, 26–34.
74. O’Connor, M.C. Packaging Maker Offering Tamper-Evident RFID Film. RFID J. Available online:
https://www.rfidjournal.com/articles/view?2959 (accessed on 24 March 2020).
75. Jo, C.L.; Ambs, A.; Dresler, C.M.; Backinger, C.L. Child-resistant and tamper-resistant packaging: A systematic review
to inform tobacco packaging regulation. Prev. Med. 2017, 95, 89–95, doi:10.1016/j.ypmed.2016.11.013.
76. Naitove, M. In food packaging, peelable IML serves as tamper-evident seal. Plast. Technol. 2018, 64, 14–16.
77. Mayberry, J. Make your mark: tamper-evident packaging remains invaluable for safety-conscious
consumers. Pharm. Process. 2013, 28, 36–37.
78. Floerkemeier, C.; Siegemund, F. Improving the effectiveness of medical treatment with pervasive
computing technologies. In Proceedings of the UbiHealth: The 2nd International Workshop on Ubiquitous
Computing for Pervasive Healthcare Applications, 2003.
79. Gao, J.; Pang, Z.; Chen, Q.; Zheng, L.R. Interactive packaging solutions based on RFID technology and
controlled delamination material. In Proceedings of the RFID 2010: International IEEE Conference on
RFID, Orlando, FL, USA, 16 April 2010; pp. 158–165, doi:10.1109/RFID.2010.5467270.
80. Choi, J.B.; Rogers, J.; Jones, E.C. The impact of a shared pharmaceutical supply chain model on counterfeit
drugs, diverted drugs, and drug shortages. In Proceedings of the Portland International Conference
on Management of Engineering and Technology (PICMET), Portland, OR, USA, 2015; pp. 1879–1889,
doi:10.1109/PICMET.2015.7273165.
81. Shah, R.Y.; Prajapati, P.N.; Agrawal, Y.K. Anticounterfeit packaging technologies. J. Adv. Pharm.
Technol. Res. 2010, 1, 368–373, doi:10.4103/0110-5558.76434.
82. Bansal, D.; Malla, S.; Gudala, K.; Tiwari, P. Anti-Counterfeit Technologies: A Pharmaceutical Industry
Perspective. Sci. Pharm. 2013, 81, 1–14, doi:10.3797/scipharm.1202-03.
83. Andria, S.E.; Fulcher, M.; Witkowski, M.R.; Platek, S.F. The Use of SEM/EDS and FT-IR Analyses in the
Identification of Counterfeit Pharmaceutical Packaging. Am. Pharm. Rev. 2012, 15, 62.
84. Li, Y.; Li, J. The Intelligent Texture Anti-counterfeiting Algorithm Based on DFT. In Proceedings of the
Ninth International Conference on Intelligent Information Hiding and Multimedia Signal Processing,
Beijing, China, 16 October 2013; pp. 590–593, doi:10.1109/IIH-MSP.2013.152.
85. Simske, S.; Mucher, P.; Martinez, C. Using variable data security printing to provide customized package
protection. Int. Conf. Digit. Prod. Print. Ind. Appl. Final. Program Proc. 2005, 3, 112–113.
86. Ishiyama, R.; Takahashi, T.; Makino, K.; Kudo, Y.; Kooper, M.; Abbink, D. Medicine Tablet
Authentication Using "Fingerprints" of Ink-Jet Printed Characters. In Proceedings of the International
Conference on Industrial Technology (ICIT), Melbourne, Australia, 15 February 2019; pp. 871–876,
doi:10.1109/ICIT.2019.8754966.
87. Fei, J.; Liu, R. Drug-laden 3D biodegradable label using QR code for anti-counterfeiting of drugs.
Mater. Sci. Eng. 2016, 63, 657–662. doi:10.1016/j.msec.2016.03.004.
88. Ludasi, K.; Jójárt-Laczkovich, O.; Sovány, T.; Hopp, B.; Smausz, T.; Regdon Jr., G. Comparison of
conventionally and naturally coloured coatings marked by laser technology for unique 2D coding of
pharmaceuticals. Int. J. Pharm. 2019, 570, 118665, doi:10.1016/j.ijpharm.2019.118665.
89. Han, S.; Bae, H.J.; Kim, J.; Shin, S.; Choi, S.; Lee, S.H.; Kwon, S.; Park, W. Lithographically encoded
polymer microtaggant using high-capacity and error-correctable QR code for anti-counterfeiting of drugs.
Adv. Mater. 2012, 24, 5924–5929, doi:10.1002/adma.201201486.
90. Platek, S.F.; Ranieri, N.; Batson, J. Applications of the FDA’s Counterfeit Detection Device (CD3+) to the
Examination of Suspect Counterfeit Pharmaceutical Tablets and Packaging. Microsc. Microanal. 2016, 22,
doi:10.1017/S1431927616006206.
91. Kwok, K.; Taylor, L.S. Analysis of the packaging enclosing a counterfeit pharmaceutical tablet using
Raman microscopy and two-dimensional correlation spectroscopy. Vib. Spectrosc. 2012, 61, 176–182,
doi:10.1016/j.vibspec.2012.02.018.
92. Eliasson, C.; Matousek, P. Noninvasive Authentication of Pharmaceutical Products through Packaging
Using Spatially Offset Raman Spectroscopy. Anal. Chem. 2007, 79, 1696–1701, doi:10.1021/ac062223z.
93. Nilsson, E.; Nilsson, B.; Järpe, E. A pharmaceutical anti-counterfeiting method using time controlled
numeric tokens. In Proceedings of the International Conference on RFID-Technologies and Applications,
Sitges, Spain, 15 March 2011; pp. 343–347, doi:10.1109/RFID-TA.2011.6068659.
Pharmacy 2020, 8, 58 18 of 18
94. Al-Bahri, M.; Yankovsky, A.; Kirichek, R.; Borodin, A. Smart System Based on DOA & IoT for Products
Monitoring & Anti-Counterfeiting. In Proceedings of the 4th MEC International Conference on Big Data
and Smart City (ICBDSC), 15 January 2019; pp. 1–5, doi:10.1109/ICBDSC.2019.8645610.
95. Garankina, R.Y.; Zakharochkina, E.R.; Samoshchenkova, I.F.; Lebedeva, N.Y.; Lebedev, A.V. Blockchain
Technology and its Use in the Area of Circulation of Pharmaceuticals. J. Pharm. Sci. Res. 2018, 10, 2715–2717.
96. Pashkov, V.; Soloviov, O. Legal implementation of blockchain technology in pharmacy. In Proceedings
of the 7th International Interdisciplinary Scientific Conference: Society, Health, Welfare, 10 October 2018;
Volume 68, pp. 1–8, doi:10.1051/shsconf/20196801027.
97. Shi, J.; Yi, D.; Kuang, J. Pharmaceutical Supply Chain Management System with Integration of IoT and Blockchain
Technology; Smart Blockchain; Qiu, M., Ed.; Springer International Publishing: Berlin/Heidelberg, Germany,
2019, pp. 97–108.
98. Ogden, J. Implementing the EU Falsified Medicines Directive. Prescriber 2019, 30, 30–33, doi:10.1002/psb.1748.
99. Nowakowski, W. The Internet of Things: from smart packaging to a world of smart objects? Elektronika
2016, 10, 70–75, doi:10.15199/13.2016.10.18.
100. Suganya, G.; Premalatha, M.; Anushka, S.; Muktak, P.; Abhishek, J. IoT based Automated Medicine
Dispenser for Online Health Community using Cloud. Int. J. Recent Technol. Eng. 2019, 7, 1–8.
101. Thakkar, H.; Trivedi, V.; Jolapara, U.; Chauhan, J. MED-IoT: A Medicine Confirmation System.
In Proceedings of the International Conference on Smart City and Emerging Technology (ICSCET), Mumbai,
India, 5 January 2018; pp. 1–5, doi:10.1109/ICSCET.2018.8537347.
102. López-Nores, M.; Pazos-Arias, J.J.; García-Duque, J.; Blanco-Fernández, Y.; Ramos-Cabrer, M. Introducing
smart packaging in residential networks to prevent medicine misuse. In Proceedings of the IEEE
International Symposium on Consumer Electronics, Las Vegas, NV, USA, 9 January 2008; pp. 1–3,
doi:10.1109/ISCE.2008.4559570.
103. Srinivas, M.; Durgaprasadarao, P.; Raj, V.N.P. Intelligent medicine box for medication management using
IoT. In Proceedings of the 2nd International Conference on Inventive Systems and Control (ICISC), 2018;
pp. 32–34, doi:10.1109/ICISC.2018.8399097.
104. da Silva, D.V.; Gonçalves, T.G.; Pires, P.F. Using IoT technologies to develop a low-cost smart medicine box.
In Proceedings of the Companion Proceedings of the 25th Brazilian Symposium on Multimedia and Web,
Espírito Santo, Brazil, 26 October 2019; pp. 97–101, doi:10.5753/webmedia_estendido.2019.8145.
105. Yang, G.; Xie, L.; Mantysalo, M.; Zhou, X.L.; Pang, Z.B.; Xu, L.D.; Kao-Walter, S.; Chen, Q.; Zheng, L.R.
A Health-IoT Platform Based on the Integration of Intelligent Packaging, Unobtrusive Bio-Sensor, and
Intelligent Medicine Box. IEEE Trans. Ind. Informatics 2014, 10, 2180–2191, doi:10.1109/Tii.2014.2307795.
106. Pang, Z.; Tian, J.; Chen, Q. Intelligent packaging and intelligent medicine box for medication
management towards the Internet-of-Things. In Proceedings of the 16th International Conference on
Advanced Communication Technology, PyeongChang, Korea, 16 February 2014; Volume 2, pp. 352–360,
doi:10.1109/ICACT.2014.6779193.
107. Farahani, B.; Firouzi, F.; Chang, V.; Badaroglu, M.; Constant, N.; Mankodiya, K. Towards fog-driven
IoT eHealth: Promises and challenges of loT in medicine and healthcare. Future Gener. Comput. Syst.
2018, 78, 659–676, doi:10.1016/j.future.2017.04.036.
108. Kumar, R.; Shin, J.; Yin, L.; You, J.M.; Meng, Y.S.; Wang, J. All-Printed, Stretchable Zn-Ag2O Rechargeable
Battery via Hyperelastic Binder for Self-Powering Wearable Electronics. Adv. Energy Mater. 2017, 7, 1–8,
doi:10.1002/aenm.201602096.
109. Garg, N.; Garg, R. Energy harvesting in IoT devices: A survey. In Proceedings of the International
Conference on Intelligent Sustainable Systems (ICISS), 2017; pp. 127–131, doi:10.1109/ISS1.2017.8389371.
110. Meile, L.; Ulrich, A.; Magno, M. Wireless Power Transmission Powering Miniaturized Low Power IoT
devices: A Review. In Proceedings of the 8th International Workshop on Advances in Sensors and
Interfaces (IWASI), Otranto, Italy, 14 June 2019; pp. 312–317, doi:10.1109/IWASI.2019.8791433.
c© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
